Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-02-17

Clinical Trial Update: Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year

View source ↗

Summary

This clinical trial update reports on quality of life outcomes for prostate cancer patients receiving androgen deprivation therapy who experience PSA doubling w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androgen deprivation therapy (Androgen deprivation therapy)

Snippet

Sponsor: Urology South Shore Research Inc. | Conditions: Prostate Cancer | Status: UNKNOWN